name,category,termsADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,INTERPRO[450001412$IPR001590:Peptidase M12B, ADAM/reprolysin, 450001561$IPR001762:Blood coagulation inhibitor, Disintegrin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002537$IPR002870:Peptidase M12B, propeptide, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450006006$IPR006586:ADAM, cysteine-rich, 450011699$IPR013032:EGF-like region, conserved site, 450016643$IPR018358:Disintegrin, conserved site]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,PIR_SUPERFAMILY[630006703$PIRSF006749:mouse meltrin alpha]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,SMART[760000042$SM00050:DISIN, 760000538$SM00608:ACR]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790001252$Protease, 790001405$signal, 790001555$transmembrane, 790001648$zinc, 790001652$zymogen]
ADAM metallopeptidase domain 21 pseudogene; ADAM metallopeptidase domain 21,UP_SEQ_FEATURE[850015303$chain:Disintegrin and metalloproteinase domain- containing protein 21, 850102480$compositionally biased region:Cys-rich, 850102585$compositionally biased region:Poly-Val, 850102883$disulfide bond, 850103526$domain:Disintegrin, 850103596$domain:EGF-like, 850104962$domain:Peptidase M12B, 850105770$glycosylation site:N-linked (GlcNAc...), 850106244$metal ion-binding site:Zinc; catalytic, 850106245$metal ion-binding site:Zinc; in inhibited form, 850117294$sequence conflict, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
AT hook, DNA binding motif, containing 1,INTERPRO[450016267$IPR017956:AT hook, DNA-binding, conserved site]
AT hook, DNA binding motif, containing 1,SMART[760000336$SM00384:AT_hook]
AT hook, DNA binding motif, containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
AT hook, DNA binding motif, containing 1,UP_SEQ_FEATURE[850002980$chain:A.T hook DNA-binding motif-containing protein 1, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850102885$DNA-binding region:A.T hook 1, 850102888$DNA-binding region:A.T hook 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
SLIT-ROBO Rho GTPase activating protein 1,INTERPRO[450000169$IPR000198:RhoGAP, 450000929$IPR001060:Fps/Fes/Fer/CIP4 homology, 450001294$IPR001452:Src homology-3 domain]
SLIT-ROBO Rho GTPase activating protein 1,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
SLIT-ROBO Rho GTPase activating protein 1,SMART[760000047$SM00055:FCH, 760000293$SM00324:RhoGAP, 760000295$SM00326:SH3]
SLIT-ROBO Rho GTPase activating protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein, 790001398$sh3 domain]
SLIT-ROBO Rho GTPase activating protein 1,UP_SEQ_FEATURE[850060966$chain:SLIT-ROBO Rho GTPase-activating protein 1, 850102566$compositionally biased region:Poly-Arg, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850103755$domain:FCH, 850105183$domain:Rho-GAP, 850105350$domain:SH3, 850106258$modified residue, 850118574$splice variant]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),INTERPRO[450000032$IPR000038:Cell division/GTP binding protein, 450000544$IPR000637:HMG-I and HMG-Y, DNA-binding, conserved site, 450001068$IPR001214:SET, 450001324$IPR001487:Bromodomain, 450001740$IPR001965:Zinc finger, PHD-type, 450002527$IPR002857:Zinc finger, CXXC-type, 450003176$IPR003616:Post-SET zinc-binding region, 450003413$IPR003888:FY-rich, N-terminal, 450003414$IPR003889:FY-rich, C-terminal, 450007148$IPR007797:AF-4 proto-oncoprotein, 450013919$IPR015479:Transcription factor AF4, 450014157$IPR015722:MLL Transcription Factor, 450014376$IPR015967:Zinc finger C4-type, RecR, 450014891$IPR016569:Methyltransferase, trithorax, 450016267$IPR017956:AT hook, DNA-binding, conserved site, 450016532$IPR018247:EF-HAND 1, 450016788$IPR018516:FY-rich, C-terminal subgroup, 450016790$IPR018518:FY-rich, N-terminal subgroup, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),OMIM_DISEASE[520002862$Leukemia, myeloid/lymphoid or mixed-lineage]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),PIR_SUPERFAMILY[630009176$PIRSF010354:Methyltransferase_trithorax, 630009177$PIRSF010354:protein methyltransferase, trithorax protein type]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),SMART[760000221$SM00249:PHD, 760000267$SM00297:BROMO, 760000286$SM00317:SET, 760000336$SM00384:AT_hook, 760000451$SM00508:PostSET, 760000481$SM00541:FYRN, 760000482$SM00542:FYRC]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000021$acute lymphoblastic leukemia, 790000053$alternative splicing, 790000109$Apoptosis, 790000206$bromodomain, 790000311$chromatin regulator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790000573$fusion protein, 790000639$gtp-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790000954$methyltransferase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001592$ubl conjugation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),UP_SEQ_FEATURE[850000532$binding site:S-adenosyl-L-methionine, 850024151$chain:Histone-lysine N-methyltransferase MLL, 850032210$chain:MLL cleavage product C180, 850032211$chain:MLL cleavage product N320, 850102393$compositionally biased region:Ala/Gly/Ser-rich, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102885$DNA-binding region:A.T hook 1, 850102888$DNA-binding region:A.T hook 2, 850102889$DNA-binding region:A.T hook 3, 850103173$domain:Bromo; divergent, 850104016$domain:FY-rich C-terminal, 850104017$domain:FY-rich N-terminal, 850105053$domain:Post-SET, 850105340$domain:SET, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850106259$mutagenesis site, 850114570$region of interest:S-adenosyl-L-methionine binding, 850117294$sequence conflict, 850117295$sequence variant, 850117891$site:Breakpoint for translocation to form MLL- AF3P21 and MLL-CASC5 oncogenes, 850117893$site:Breakpoint for translocation to form MLL- AFF4 fusion protein, 850117896$site:Breakpoint for translocation to form MLL- CENPK oncogene, 850117899$site:Breakpoint for translocation to form MLL- FRYL fusion protein, 850117900$site:Breakpoint for translocation to form MLL- GAS7 oncogene, 850117901$site:Breakpoint for translocation to form MLL- LPP, 850117905$site:Breakpoint for translocation to form MLL- ZFYVE19 oncogene, 850118120$site:Cleavage; by TASP1, site 1, 850118121$site:Cleavage; by TASP1, site 2, 850118293$site:Important for WDR5-recognition and binding, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118796$zinc finger region:CXXC-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2, 850118883$zinc finger region:PHD-type 3]
tumor necrosis factor (ligand) superfamily, member 11,BIOCARTA[30000250$h_ranklPathway:Bone Remodelling]
tumor necrosis factor (ligand) superfamily, member 11,INTERPRO[450005489$IPR006052:Tumor Necrosis Factor, 450008180$IPR008983:Tumour necrosis factor-like, 450015679$IPR017355:Tumour necrosis factor ligand superfamily member, 10/11]
tumor necrosis factor (ligand) superfamily, member 11,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction]
tumor necrosis factor (ligand) superfamily, member 11,OMIM_DISEASE[520003402$Multiple Genetic Loci for Bone Mineral Density and Fractures, 520003635$New sequence variants associated with bone mineral density, 520003822$Osteopetrosis, autosomal recessive 2]
tumor necrosis factor (ligand) superfamily, member 11,PIR_SUPERFAMILY[630029590$PIRSF038013:TNF10_TNF11, 630029591$PIRSF038013:tumor necrosis factor ligand superfamily member, 10/11 types]
tumor necrosis factor (ligand) superfamily, member 11,SMART[760000180$SM00207:TNF]
tumor necrosis factor (ligand) superfamily, member 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000402$cytokine, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000616$glycoprotein, 790000919$membrane, 790001084$osteopetrosis, 790001301$receptor, 790001363$Secreted, 790001409$Signal-anchor, 790001555$transmembrane]
tumor necrosis factor (ligand) superfamily, member 11,UP_SEQ_FEATURE[850067172$chain:Tumor necrosis factor ligand superfamily member 11, membrane form, 850067173$chain:Tumor necrosis factor ligand superfamily member 11, soluble form, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117969$site:Cleavage, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
